Meda Pharmaceuticals Inc v. Asst Controller Of Patents And Designs

133328191

This case was transferred from the Intellectual Property Appellate Board (IPAB) to the Calcutta High Court following the enactment of the Tribunals Reform Act, 2021. The court directed the Commercial Appellate Division to issue notices and file a report before setting the next hearing date.

Jurisdiction
India
Court
Calcutta High Court
Case Number
133328191
Judge(s)
Ravi Krishan Kapur

Detailed Summary

of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Calcutta High Court. Understanding the court's reasoning in Meda Pharmaceuticals Inc vs Asst Controller Of Patents And Designs is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patent57717190

Metro Institutes of Medical Sciences Pvt LtdvsMetro International Cardiac Centre & Ors

The plaintiff, Metro Institutes of Medical Sciences Pvt Ltd, filed a suit seeking an injunction against the defendants for using the 'METRO' trade name/trademark in respect of medical services. The plaintiff claimed extensive goodwill and reputation associated with its hospitals under the METRO brand. However, the court dismissed the interim injunction application, finding that the plaintiff lacked a prima facie case and there was no evidence suggesting the defendant was a dishonest concurrent user.

patent43606532

Mankind Pharma LimitedvsNeospark Drugs And Chemicals Private Limited; The Registrar of Trade Marks

The Madras High Court ruled in favor of Mankind Pharma Limited, directing the removal of the trademark MAXCAL GEL (No. 2102511) from the Trade Marks Register. The court found that the registration had lapsed and was not renewed within the statutory time limits. This decision underscores the strict adherence required to maintain trademark rights through timely renewal procedures.

patent151588149

Societe Des Produits Nestle S AvsThe Registrar Of Trade Marks

Nestle appealed a trademark refusal order from the Trademark Registry to the Delhi High Court. The original rejection was based on the mark being non-distinctive and similar to existing registered marks. Due to procedural issues following the dissolution of the IPAB, Nestle had to file a fresh appeal in the High Court. The court accepted notice and scheduled further proceedings.

patent55471842

Phillip Morris Produts S AvsAssistant Controller Of Patents And Design

Phillip Morris Produts S A filed an appeal challenging the Assistant Controller's refusal to grant a patent application. The Controller refused the grant on the ground that the invention related to tobacco use, which causes serious prejudice to human life or health, making it ineligible under Section 3(b) of the Patents Act, 1970.

patent53793115

Vinod Kumar LakhotiyavsThe Registrar Of Trade Marks, (Govt. Of India)

In this writ petition, Vinod Kumar Lakhotiya sought judicial intervention to expedite the pending registration of his trademark 'LAKHOTIA DURGA' in Class 29. The petitioner argued that previous opposition had been resolved through a compromise and there was no longer any impediment to registration. The Rajasthan High Court agreed with the prayer, issuing a mandamus-like direction to the Registrar of Trade Marks to decide the application expeditiously, preferably within eight weeks.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call